HB 43

  • Alaska House Bill
  • 30th Legislature (2017-2018)
  • Introduced in House Apr 11, 2017
  • Passed House Apr 10, 2017
  • Passed Senate Apr 25, 2018
  • Signed by Governor Nov 07, 2018

An Act relating to prescribing, dispensing, and administering an investigational drug, biological product, or device by physicians for patients who are terminally ill for the purpose of sustaining the patient's life; providing immunity related to manufacturing, distributing, or providing investigational drugs, biological products, or devices; and relating to licensed health care facility requirements.

Votes


Actions


Nov 07, 2018

House

EFFECTIVE DATE(S) OF LAW 10/11/18

House

1:37 PM 7/9/18 Transmitted to Governor

House

Signed into law 7/13 CHAPTER 53 SLA 18

Apr 28, 2018

House

MANIFEST ERROR(S)

Apr 25, 2018

Senate

RETURN TO (H), TRANSMIT TO GOV NEXT

Senate

CROSS SPONSOR(S): VON IMHOF

Senate

PASSED Y20 N-

Senate

MICCICHE, GARDNER, HUGHES, BEGICH, EGAN, MEYER

Senate

CROSS SPONSOR(S): WIELECHOWSKI, SHOWER, COSTELLO, GIESSEL, BISHOP, MACKINNON

Senate

Read the third time CSHB 43(JUD)

Senate

ADVANCED TO THIRD READING UC

Senate

Read the second time

Senate

RULES TO CALENDAR 4/25/2018

Senate

VERSION: CSHB 43(JUD)

Mar 28, 2018

Senate

JUD RPT 2DP 3NR

Senate

Fiscal Note 2: No fiscal impact (Commerce, Community & Economic Development)

Senate

JUD No Recommendation: COSTELLO, KELLY, SHOWER

Senate

JUD Do Pass: COGHILL, WIELECHOWSKI

Jan 31, 2018

Senate

HSS Do Pass: VON IMHOF, BEGICH, GIESSEL

Senate

HSS No Recommendation: MICCICHE

Senate

Fiscal Note 2: No fiscal impact (Commerce, Community & Economic Development)

Senate

HSS RPT 3DP 1NR

Apr 11, 2017

Senate

Referred to Health & Social Services and Judiciary

Senate

Read the first time - REFERRALS

Apr 10, 2017

House

VERSION: CSHB 43(JUD)

House

MOVED TO BOTTOM OF CALENDAR

House

MOVED TO BOTTOM OF CALENDAR

House

Read the third time CSHB 43(JUD)

House

PASSED Y40

House

Cosponsors added: GUTTENBERG, KNOPP, TARR, JOSEPHSON, TILTON, RAUSCHER

House

TRANSMITTED TO (S)

Apr 09, 2017

House

RULES TO CALENDAR 4/9/2017

House

Cosponsors added: FANSLER, PARISH

House

ADVANCED TO THIRD READING 4/10 CALENDAR

House

JUD CS ADOPTED UC

House

Read the second time

Apr 05, 2017

House

JUD Do Pass: EASTMAN, KOPP, FANSLER, LEDOUX, CLAMAN

House

Cosponsors added: LEDOUX, EASTMAN

House

Fiscal Note 1: No fiscal impact (Commerce, Community & Economic Development)

House

JUD No Recommendation: REINBOLD

House

JUD RPT CS(JUD) NT 5DP 1NR

Mar 08, 2017

House

HSS Do Pass: JOHNSTON, TARR, EDGMON, SULLIVAN-LEONARD, SPOHNHOLZ

House

Fiscal Note 1: No fiscal impact (Commerce, Community & Economic Development)

House

HSS Amend: EASTMAN

House

HSS No Recommendation: KITO

House

HSS RPT 5DP 1NR 1AM

Jan 18, 2017

House

Read the first time - REFERRALS

House

Referred to Health & Social Services and Judiciary

Jan 13, 2017

House

Prefile released

Bill Text

Bill Text Versions Format
HB0043Z HTML
HB0043B HTML
HB0043A HTML

Related Documents

Document Format
HB 43 Powerpoint Presentation.pdf
HB043 Fiscal Note DCCED--DCBPL 2.28.17.pdf
HB43 Supporting Document - Letters of Support 2.27.17.pdf
HB043 Supporting Document - Goldwater Institute Policy Report Summary 2.22.17.pdf
HB043 Supporting Document - Goldwater Institute Patient Stories 2.22.17.pdf
HB043 Supporting Document - Goldwater Institute Fact Sheet 2.22.17.pdf
HB043 Supporting Document - Clinical Trials in Alaska.pdf
HB043 Supporting Document - FDA Drug Review Process 2.22.17.pdf
HB043 Supporting Document - Legislative Map 2.22.17.pdf
HB043 Sectional Analysis ver D 2.22.17.pdf
HB043 Sponsor Statement 2.22.17.pdf
HB043 ver D 2.22.17.PDF
HB043 Supporting Document - Goldwater Institute Policy Report.pdf
HB043 Supporting Document - Letters of Support 3.2.17.pdf
HB043 Fiscal Note DCCED-CBPL 3.14.17.pdf
HB043 Powerpoint Presentation with Video.pptx
HB43 Additional Document-Powerpoint Presentation 3.27.17.pdf
HB043 Additional Document-Letter from Premera 3.27.17.pdf
HB043 Supporting Document-Letters and Emails of Support 3.14.17.pdf
HB043 Supporting Document-Clinical Trials in Alaska 3.14.17.pdf
HB043 Supporting Document-Goldwater Institute Patient Stories 3.14.17.pdf
HB043 Supporting Document-Goldwater Institute Fact Sheet 3.14.17.pdf
HB043 Supporting Document-FDA Drug Review Process 3.14.17.pdf
HB043 Supporting Document-Legislative Map 3.14.17.pdf
HB043 Sponsor Statement 3.14.17.pdf
HB043 Amendments #1-2 HJUD Final Votes 4.3.17.pdf
HB043 Amendments #1-2 3.31.17.pdf
HB043 Sectional Analysis ver D 3.14.17.pdf
HB043 ver D 3.14.17.PDF
HB43 ver J.PDF
HB43 Supporting Document - Letters of Support 4.11.17.pdf
HB43 Supporting Document - Legislative Map.pdf
HB43 Supporting Document - Goldwater Institute Patient Stories.pdf
HB43 Supporting Document - Goldwater Institute Fact Sheet.pdf
HB43 Supporting Document - FDA Drug Review Process.pdf
HB43 Supporting Document - Clinical Trials in Alaska.pdf
HB43 Sponsor Statement.pdf
HB43 Sectional Analysis ver J.pdf
HB43 Powerpoint Presentation 1.20.2018.pdf
HB43 Fiscal Note DCCED-CBPL-01-19-18.pdf
HB43 Explanation of Changes D to J.pdf
HB43 Additional Document - Letter from Premera.pdf
HB 43 - Sponsor Statement.pdf
HB 43 - Sectional Analysis (ver. J).pdf
HB 43 - Presentation.pdf
HB 43 - Letters of Support.pdf
HB 43 - Explanation of Changes (ver. D to ver. J).pdf
HB 43 - Supporting Document - Letter from Premera.pdf
HB 43 - Supporting Document - Legislative Map.pdf
HB 43 - Supporting Document - Goldwater Institute Patient Stories.pdf
HB 43 - Supporting Document - Goldwater Institute Fact Sheet.pdf
HB 43 - Supporting Document - Clinical Trials in Alaska.pdf
HB 43 - Supporting Document - FDA Drug Review Process.pdf

Sources

Data on Open States is updated periodically throughout the day from the official website of the Alaska State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.